Meiji Yasuda Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.74M Buy
12,493
+129
+1% +$18.1K 0.09% 231
2025
Q4
$1.52M Buy
12,364
+2,324
+23% +$282K 0.07% 229
2025
Q3
$1.11M Buy
10,040
+575
+6% +$65.4K 0.05% 251
2025
Q2
$1.05M Sell
9,465
-15,850
-63% -$1.69M 0.05% 258
2025
Q1
$2.84M Sell
25,315
-448
-2% -$46.2K 0.11% 199
2024
Q4
$2.38M Buy
25,763
+1,370
+6% +$123K 0.09% 208
2024
Q3
$2.05M Sell
24,393
-34
-0.1% -$2.59K 0.08% 226
2024
Q2
$1.68M Sell
24,427
-24,623
-50% -$1.64M 0.07% 239
2024
Q1
$3.59M Sell
49,050
-29,500
-38% -$2.27M 0.15% 161
2023
Q4
$6.36M Sell
78,550
-3,957
-5% -$308K 0.29% 106
2023
Q3
$6.18M Buy
82,507
+33,951
+70% +$2.61M 0.29% 104
2023
Q2
$3.74M Sell
48,556
-283
-0.6% -$22.6K 0.19% 153
2023
Q1
$4.05M Sell
48,839
-31,766
-39% -$2.63M 0.21% 144
2022
Q4
$6.92K Sell
80,605
-9,550
-11% -$756K 0.33% 85
2022
Q3
$5.56M Sell
90,155
-1,680
-2% -$106K 0.32% 92
2022
Q2
$5.68M Sell
91,835
-19,365
-17% -$1.2M 0.33% 81
2022
Q1
$6.61M Sell
111,200
-5,328
-5% -$341K 0.36% 63
2021
Q4
$8.46M Buy
116,528
+23,255
+25% +$1.6M 0.52% 44
2021
Q3
$6.51M Buy
93,273
+38
+0% +$2.67K 0.46% 57
2021
Q2
$6.42M Sell
93,235
-23,543
-20% -$1.57M 0.3% 74
2021
Q1
$7.55M Buy
116,778
+21,909
+23% +$1.41M 0.56% 43
2020
Q4
$5.53M Buy
94,869
+19,220
+25% +$1.16M 0.55% 47
2020
Q3
$4.78M Sell
75,649
-9,180
-11% -$637K 0.53% 43
2020
Q2
$6.53M Buy
84,829
+48,685
+135% +$3.73M 0.62% 39
2020
Q1
$2.7M Sell
36,144
-10,990
-23% -$759K 0.51% 51
2019
Q4
$3.06M Sell
47,134
-5,590
-11% -$364K 0.26% 111
2019
Q3
$3.34M Buy
52,724
+4,700
+10% +$307K 0.27% 98
2019
Q2
$3.25M Sell
48,024
-8,061
-14% -$530K 0.27% 101
2019
Q1
$3.65M Sell
56,085
-539
-1% -$35.8K 0.31% 87
2018
Q4
$3.54M Sell
56,624
-3,262
-5% -$228K 0.33% 81
2018
Q3
$4.62M Buy
59,886
+9,110
+18% +$688K 0.38% 73
2018
Q2
$3.6M Buy
50,776
+590
+1% +$41.7K 0.32% 83
2018
Q1
$3.78M Sell
50,186
-3,647
-7% -$290K 0.36% 77
2017
Q4
$3.86M Sell
53,833
-2,556
-5% -$194K 0.37% 75
2017
Q3
$4.57M Buy
56,389
+410
+0.7% +$31.4K 0.45% 59
2017
Q2
$3.96M Buy
55,979
+460
+0.8% +$30.6K 0.41% 69
2017
Q1
$3.77M Sell
55,519
-416
-0.7% -$29.3K 0.4% 72
2016
Q4
$4.01M Buy
55,935
+1,763
+3% +$131K 0.45% 61
2016
Q3
$4.29M Buy
54,172
+4,966
+10% +$403K 0.5% 56
2016
Q2
$4.11M Buy
49,206
+8,391
+21% +$745K 0.59% 45
2016
Q1
$3.75M Sell
40,815
-4,340
-10% -$391K 0.85% 33
2015
Q4
$4.57M Buy
45,155
+1,802
+4% +$188K 1.04% 21
2015
Q3
$4.26M Buy
43,353
+955
+2% +$106K 1.04% 20
2015
Q2
$4.96M Buy
42,398
+919
+2% +$100K 1.17% 14
2015
Q1
$4.07M Sell
41,479
-3,393
-8% -$345K 0.98% 18
2014
Q4
$4.23M Sell
44,872
-2,308
-5% -$239K 1.02% 17
2014
Q3
$5.02M Sell
47,180
-9,228
-16% -$904K 1.18% 13
2014
Q2
$4.68M Buy
56,408
+2,602
+5% +$203K 0.96% 21
2014
Q1
$3.81M Sell
53,806
-3,010
-5% -$236K 0.82% 31
2013
Q4
$4.27M Buy
56,816
+258
+0.5% +$18K 0.9% 25
2013
Q3
$3.55M Buy
56,558
+1,054
+2% +$63K 0.8% 33
2013
Q2
$2.84M Buy
+55,504
New +$2.89M 0.67% 47

Other funds holding GILD

Meiji Yasuda Asset Management's GILD Position: Q1 2026 in Review

Meiji Yasuda Asset Management increased its Gilead Sciences (GILD) stake by 1% in Q1 2026, buying an estimated $18.1K and bringing the position to 12,493 shares worth $1.74M. The position accounts for 0.09% of the portfolio, ranked #231.

Meiji Yasuda Asset Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.46M in Q4 2021. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Meiji Yasuda Asset Management held 12,493 shares of Gilead Sciences worth $1.74M as of Q1 2026.
  • Meiji Yasuda Asset Management bought 129 Gilead Sciences shares in Q1 2026, an estimated $18.1K.
  • Gilead Sciences made up 0.09% of Meiji Yasuda Asset Management's portfolio in Q1 2026, its #231 holding.
  • Meiji Yasuda Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Meiji Yasuda Asset Management's Gilead Sciences position peaked at $8.46M in Q4 2021.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Meiji Yasuda Asset Management's 13F filing for Q1 2026, filed 14 May 2026.